The only absolute contraindication to the use of<unk>  is hypersensitivity to the active ingredient or any component of the formulation. In children under the age of five or those who weigh less than , there is limited data regarding the efficacy or safety of<unk> , though the available data demonstrate few adverse effects. However, the American Academy of Pediatrics cautions against use of<unk>  in such patients, as the blood-brain barrier is less developed, and thus there may be an increased risk of particular CNS side effects such as encephalopathy, ataxia, coma, or death. Such patients should be monitored very closely when given<unk> . The American Academy of Family Physicians also recommends against use in these patients, given a lack of sufficient data to prove drug safety.<unk>  is secreted in very low concentration in breast milk. It remains unclear if<unk>  is safe during pregnancy.
Ivermectin
Avermectin
Praziquantel
Mebendazole
Albendazole
Flubendazole
Pyrantel
Artemether